Blood Tests for Brain-Injury Biomarkers Could Be Used to Monitor Patients with Moderate to Severe COVID-19
Some COVID-19 patients exhibit clinical and neurochemical signs of brain injury, according to a new study which showed that finding and measuring a blood-based biomarker for brain damage proved to be possible. More...04 Aug 2021
Cepheid Developing New COVID-19 Diagnostics for Pooled Samples and Rapid Detection of SARS-Cov-2 Variants
Cepheid, Inc. (Sunnyvale, CA, USA) is collaborating with the Biomedical Advanced Research and Development Authority (BARDA; Washington, DC, USA) on rapid diagnostic testing for pooled samples to address COVID-19, detect novel and emerging coronaviruses, and increase pandemic preparedness. More...03 Aug 2021
Next Generation End-To-End Digital COVID-19 Screening Solution to Help Prevent Outbreaks
With connected point-of-care screening becoming a critical security mechanism of the post-pandemic normalcy, a new next generation end-to-end COVID-19 screening solution could help prevent future outbreaks. More...03 Aug 2021
PCR of Gargle Lavage Samples as Effective as Nasopharyngeal Swabs to Identify SARS-CoV-2 Infection, Finds Study
Twenty-six subjects from a cohort of 80 tested positive for SARS-CoV-2 via nasopharyngeal swab, and all 26 tested positive using gargle lavage (mouthwash), according to new research. More...30 Jul 2021
CerTest Launches VIASURE SARS-CoV-2 Variant II Real Time PCR Detection Kit
CerTest Biotec (Zaragoza, Spain) has launched VIASURE SARS-CoV-2 Variant II Real Time PCR Detection Kit, a real-time RT-PCR test designed for the qualitative detection of RNA from genetic mutations in the S gene (P681R, L452R and E484Q) from positive SARS-CoV-2 nasopharyngeal samples. More...30 Jul 2021
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Multi-Function Pipetting Platform
apricot PP5
In Other News
Breakthrough Identification of First Saliva Activated Biosensor Molecules to Diagnose COVID-19 Paves Way for New Oral Screening Test
COVID-19 Severity Test Reads Immune System in Real Time Using Machine Learning for Predicting Severe Outcomes
Ultra-Fast, Fully Automated SARS-CoV-2 Virus Detection Test Uniquely Suited for Near Patient Testing
Less-Sensitive COVID-19 Tests Could Still Achieve Optimal Results If Enough People Are Tested
Same Nasal Swabs Used to Diagnose COVID-19 Could Also Identity Potentially Severe Cases
Eurofins Viracor Launches Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity Testing to Aid COVID-19 Treatment Decisions
Microarray-Based COVID-19 Test Analyzes Sample in Triplicate for Each Patient Swab Within Each Array For 100% Specificity
Non-Invasive COVID-19 Diagnostic System Collects Sample Droplets from Lungs and Returns Results in 10 Minutes
AACC Publishes New COVID-19 Guidelines for Clinical Laboratories
Novel T-Cell Test for SARS-CoV-2 Can Help Monitor Cellular Immunity Against COVID-19
Enzo Biochem Receives FDA EUA for Rapid Extraction Method on Proprietary Test System for Detection of SARS-CoV-2
Serum Biomarkers Enable Tracing the Progress of COVID-19 Infections
Rapid Olfactory Test Shows Potential as Screening Tool for COVID-19
New Diagnostic Test Could Detect Biological ‘Fingerprints’ of Long COVID in Blood
Artificial Intelligence (AI) Model Identifies COVID-19 Patients Using Blood Tests and Chest X-Rays
First-Ever Serology Test Built on Multiparameter Flow Cytometry Platform Differentiates Between COVID-19 Infection and Vaccination Antibodies
New Highly Sensitive Blood Test Accurately Measures Immunity Against SARS-CoV-2
Two-Minute COVID-19 Test Uses Nanosensor Technology to Detect Presence of SARS-CoV-2 Infection in Blood at POC
Global Lateral Flow Assays Market to Reach USD 11.2 Billion by 2026 Due to Robust Demand for COVID-19 Screening Tests
Lateral Flow Tests Detect COVID-19 with Similar Accuracy to Laboratory-Based PCR Tests When Used at Onset of Symptoms
Seegene Launches New Multiplex PCR Test Capable of Screening Six SARS-CoV-2 Variants
Blood Test That Quantifies Protein ACE2 and ACE2 Fragments Can Monitor SARS-CoV-2 Infection
Global COVID-19 Diagnostic Market to Reach USD 65.75 Billion by 2028
